Published in Ann Intern Med on January 01, 1973
Ovarian tumors. A review. Am J Pathol (1977) 2.90
Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. Rev Urol (2002) 1.71
Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci U S A (1976) 1.33
An immunohistochemical study of the significance of HCG secretion by large bowel adenocarcinomata. J Clin Pathol (1979) 1.26
trans-acting factors interact with a cyclic AMP response element to modulate expression of the human gonadotropin alpha gene. Mol Cell Biol (1987) 1.17
In vitro secretion of human chorionic gonadotrophin by bladder tumour cells. Br J Cancer (1987) 1.08
Cytological localization of chorionic gonadotropin alpha and placental lactogen mRNAs during development of the human placenta. J Cell Biol (1982) 1.07
Human chorionic gonadotropin radioantibodies in the radioimmunodetection of cancer and for disclosure of occult metastases. Proc Natl Acad Sci U S A (1981) 1.06
False-positive urine pregnancy test due to leukocyte interference. Ann Lab Med (2012) 1.06
Detection of pregnancy specific beta1-glycoprotein in formalin-fixed tissues. J Clin Pathol (1977) 1.03
Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin. Proc Natl Acad Sci U S A (1976) 1.01
Ectopic production of the isolated beta subunit of human chorionic gonadotropin. J Clin Invest (1973) 0.95
Serum alpha1-foetoprotein levels in 153 male patients with germ cell tumours. Br J Cancer (1977) 0.94
High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature. J Cancer Res Clin Oncol (2004) 0.93
Serum and urinary levels of beta human chorionic gonadotrophin in patients with transitional cell carcinoma. Br J Cancer (1991) 0.93
Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine 'normal' and malignant epithelial cells. Br J Cancer (1990) 0.93
Ectopic production of human chorionic gonadotrophin by human breast tumours. Br J Cancer (1974) 0.92
Case report: elevated serum beta human chorionic gonadotropin in a woman with osteosarcoma. Clin Orthop Relat Res (2008) 0.91
Serum biochemical markers in lung cancer. Br J Cancer (1978) 0.89
Beta human chorionic gonadotropin concentrations in serum of patients with pancreatic adenocarcinoma. Gut (1998) 0.86
Human chorionic gonadotropin measurements in parathyroid carcinoma. Eur J Endocrinol (2008) 0.84
Tumor-associated bacteria capable of producing a human choriogonadotropin-like substance. Infect Immun (1981) 0.84
Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis. Br J Cancer (1989) 0.80
Fetal tissue can synthesize a placental hormone. Evidence for chorionic gonadotropin beta-subunit synthesis by human fetal kidney. J Clin Invest (1981) 0.79
Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors. Int J Mol Sci (2012) 0.77
Nononcologic disease in patients with cancer. West J Med (1977) 0.76
Human chorionic gonadotropin-like proteins: secretion in nonpregnant humans and production by bacteria. Trans Am Clin Climatol Assoc (1992) 0.75
Gallbladder adenocarcinoma with human chorionic gonadotropin: a case report and review of literature. Diagn Pathol (2010) 0.75
Germ cell tumors of the testes. West J Med (1977) 0.75
Expression of human chorionic gonadotropin beta in gastric carcinoma: A retrospective immunohistochemical study. Indian J Med Paediatr Oncol (2009) 0.75
The role of immunocytochemistry in tumour pathology: a review. J R Soc Med (1980) 0.75
Endocrinology and treatment of trophoblastic tumours. J Clin Pathol Suppl (R Coll Pathol) (1976) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16
Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98
Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03
A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab (1971) 4.38
Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54
Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med (1994) 3.38
Production of antisera with small doses of immunogen: multiple intradermal injections. Methods Enzymol (1981) 3.37
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med (2000) 3.00
A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol (1972) 2.76
Statistical quality control of radioimmunoassays. J Clin Endocrinol Metab (1968) 2.41
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst (1990) 1.97
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94
Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88
Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med (1973) 1.83
Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies. J Clin Invest (1967) 1.82
Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles. Recent Prog Horm Res (1970) 1.82
Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol (1994) 1.79
Pseudohyperkalemia due to release of potassium from white blood cells during clotting. N Engl J Med (1966) 1.73
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71
Serum human chorionic gonadotropin levels throughout normal pregnancy. Am J Obstet Gynecol (1976) 1.71
Gonadotropins and their subunits: basic and clinical studies. Recent Prog Horm Res (1976) 1.66
Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res (1966) 1.62
Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab (1972) 1.61
Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med (1966) 1.58
Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) (1987) 1.50
Effects of anabolic-androgenic steroids on muscular strength. Ann Intern Med (1991) 1.47
First-trimester chorionic gonadotropin measurements as an aid in the diagnosis of early pregnancy disorders. Am J Obstet Gynecol (1978) 1.46
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Serum concentrations of two endometrial proteins are not useful for monitoring postmenopausal estrogen/progesterone therapy. Fertil Steril (1990) 1.39
Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: comparison with normal men, prepuberal boys, and hypopituitary patients. J Clin Invest (1969) 1.38
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women. J Clin Invest (1968) 1.37
The value of a hospitalist service: efficient care for the aging population? Chest (2001) 1.36
Pathophysiology of acromegaly. Endocr Rev (1983) 1.35
Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA (1966) 1.34
Cancer treatment and age: patient perspectives. J Natl Cancer Inst (1993) 1.34
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Simplified, partially automated method for radioimmunoassay of human thyroid-stimulating, growth, luteinizing, and follicle stimulating hormones. J Lab Clin Med (1967) 1.33
Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A. J Natl Cancer Inst (1972) 1.32
Radioimmunoassay for human luteinizing hormone. Metabolism (1966) 1.32
Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29
In vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst (1971) 1.27
Estrogen and follicle stimulation hormone interactions on follicle growth in rats. Endocrinology (1972) 1.27
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood (1968) 1.26
Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer (1971) 1.25
Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am J Med (1967) 1.25
Modification of the choriogonadotropin beta-subunit radioimmunoassay for determination of urinary choriogonadotropin. Clin Chem (1978) 1.22
Plasma gonadotropins during clomiphene induced ovulatory cycles. Am J Obstet Gynecol (1968) 1.22
Polycystic-ovary syndrome--what is it? N Engl J Med (1983) 1.20
Changing placental concentrations of human chorionic gonadotropin and its subunits during gestation. J Clin Endocrinol Metab (1974) 1.18
Properties of the subunits of human chorionic gonadotropin. Endocrinology (1974) 1.18
Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res (1968) 1.16
Central nervous system involvement in Burkitt's lymphoma. Blood (1970) 1.16
The health consequences of smoking. Cancer. Med Clin North Am (1992) 1.15
Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer (1983) 1.14
Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood (1971) 1.14
Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland. Eur J Cancer (1978) 1.13
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial. Cancer (1978) 1.13
Effects of induced hyperthyroidism on steroid metabolism in man. J Clin Endocrinol Metab (1971) 1.12
Site of action of clomiphene citrate in men: a study of the pituitary-Leydig cell axis. J Clin Endocrinol Metab (1967) 1.12
Pregnancies after chemotherapy of trophoblastic neoplasms. Science (1970) 1.12
A lesson from the mammography issue. Ann Intern Med (1978) 1.11
Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma. Thyroid (2001) 1.11
Lymphoma of the breast. Ann Surg (1981) 1.11
Production rates and metabolic clearance rates of human follicle-stimulating hormone in premenopausal and postmenopausal women. J Clin Invest (1969) 1.10
Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin. J Clin Endocrinol Metab (1974) 1.10
Do thyroid function tests independently predict survival in the critically ill? Thyroid (1992) 1.10
Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med (1976) 1.08
Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol (1986) 1.08
Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. Cancer Res (1965) 1.08
Presence in normal human testes of a chorionic-gonadotropin-like substance distinct from human luteinizing hormone. N Engl J Med (1975) 1.07
Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1967) 1.07
Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res (1973) 1.07
Acetohydroxamate: bacterial urease inhibitor with therapeutic potential in hyperammonaemic states. Nature (1965) 1.07
Gynecomastia: pathomechanisms and treatment strategies. Horm Res (1997) 1.06
Immunological and biological activity of HCG following progressive desialylation. Endocrinology (1971) 1.06
Diagnostic problems of choriocarcinoma and related trophoblastic neoplasms. Obstet Gynecol (1967) 1.06
Follicle-stimulating hormone (FSH) and luteninizing hormone (LH) in the urine of prepubertal children. J Clin Invest (1967) 1.05
The short luteal phase. J Clin Endocrinol Metab (1970) 1.05
In vivo and in vitro production of human chorionic gonadotropin and alpha-feteoprotein by a virilizing hepatoblastoma. J Clin Endocrinol Metab (1972) 1.04
Serum immune globulin concentrations in acute leukemia during intensive chemotherapy. Cancer (1965) 1.03
Gonadotropins and preantral follicular maturation in women. Fertil Steril (1974) 1.03
Cerebellar dysfunction in Hand-Schueller-Christian disease. Arch Intern Med (1973) 1.03
Secretory rates of human chorionic gonadotropin by normal trophoblast. Am J Obstet Gynecol (1973) 1.02